PI
Harm Reduction Innovation Lab, Rhode Island Hospital
Brown University, Maryland
Dr. Ju Nyeong Park, Ph.D., M.H.S., is an Assistant Professor (Research) in the Division of General Internal Medicine at Brown University and a Research Scientist at Rhode Island Hospital. Dr. Park co-directs the research track of the Brown Internal Medicine Residency Program and has a secondary appointment in the Department of Epidemiology at Brown University School of Public Health. She earned her Ph.D. and M.H.S. in Epidemiology at Johns Hopkins University and B.S. in Neuroscience from the University of Sydney.
Dr. Park's team, the Harm Reduction Innovation Lab (HRIL) is based at Rhode Island Hospital. HRIL's mission is to implement, and evaluate innovative interventions to promote the health and wellbeing of people who use drugs, including overdose detection technologies, overdose prevention centers (also known as supervised consumption sites), and community-based drug checking programs. Currently, Dr. Park is a Principal Investigator on a Center of Biomedical Research Excellence (COBRE) on Opioids and Overdose Research Project Leader grant funded by the National Institute of General Medical Sciences examining overdose detection technologies (P20GM125507) and an evaluation grant funded by the Patterson Trust. She also serves as a Co-Investigator on two NIDA-funded studies: (1) The CUTS drug checking cohort study (UG3DA056881), and (2) a OUD-Sleep cohort study (R01DA059469). Dr. Park has extensive experience conducting epidemiologic studies, mixed-methods studies, prospective cohort studies and surveillance studies. She has published over 90 peer-reviewed publications on substance use, HIV and overdose, and her research has been featured in media outlets including the New York Times, CNN and Al Jazeera. She serves on the Editorial Board of the International Journal of Drug Policy.
Disclosure information not submitted.
Thursday, October 17, 2024
11:10 AM – 11:30 AM ET